{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T08:01:49Z","timestamp":1783238509534,"version":"3.54.6"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T00:00:00Z","timestamp":1734652800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T00:00:00Z","timestamp":1734652800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiol med"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>Personalized treatment schemes are being systematically applied to ensure best treatment outcome in oncologic patients. This is true also for personalized dosimetry in transarterial radioembolization (TARE) in hepatocellular carcinoma (HCC) patients. Precise and detailed volumetric and functional data derived from radiological and nuclear imaging methods are essential for personalized dosimetry. We sought to evaluate accuracy of dual-phase cone-beam CT (CBCT) in comparison to pre-treatment contrast-enhanced CT (CECT), and <jats:sup>99m<\/jats:sup>Tc-macroaggregated albumin-SPECT\/CT ([<jats:sup>99m<\/jats:sup>Tc]MAA SPECT\/CT) to predict and assess the efficacy of TARE based on post-treatment <jats:sup>90<\/jats:sup>Y PET\/CT.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Material and methods<\/jats:title>\n            <jats:p>Thirty consecutive patients with HCC treated with TARE were included. Intraprocedural dual-phase CBCT acquisition protocol was developed to distinguish tumor volume in the early arterial phase and perfused volume of non-affected liver in the late arterial phase. Volumetric data obtained from pre-treatment CECT, dual-phase CBCT and [<jats:sup>99<\/jats:sup>\n              <jats:sup>m<\/jats:sup>Tc]MAA SPECT\/CT were compared to post-treatment <jats:sup>90<\/jats:sup>Y PET\/CT considered the standard reference. Treatment simulations for final calculated dose from the different imaging derived volumes were then compared to post-treatment <jats:sup>90<\/jats:sup>Y PET\/CT.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>CBCT resulted as the most accurate method in predicting tumor- (R<jats:sup>2<\/jats:sup> 0.89) and perfused volumes (R<jats:sup>2<\/jats:sup> 0.84). Dosimetry prediction planning performed on derived volumes from the different methods did not show significant difference, yet highest concordance with <jats:sup>90<\/jats:sup>Y PET\/CT data was observed with dual-phase CBCT.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Our study shows that dual-phase CBCT acquisition is a novel alternative method for correctly and safely administering more accurate and defined doses during TARE.<\/jats:p>\n            <jats:p>\n              <jats:italic>clinicaltrials<\/jats:italic>.gov ID: NCT03981497.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s11547-024-01946-0","type":"journal-article","created":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T18:39:33Z","timestamp":1734719973000},"page":"474-485","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Radioembolization for Hepatocellular Carcinoma: a Comparison on Dual-phase Cone-beam CT, Contrast-enhanced CT (CECT)\u00a0and 99mTc-macroaggregated albumin-SPECT\/CT in predicting final distribution volumes and dosimetry of the post-embolization 90Y PET\/CT"],"prefix":"10.1007","volume":"130","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-9288-7966","authenticated-orcid":false,"given":"Ettore","family":"di Gaeta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2344-3865","authenticated-orcid":false,"given":"Michela","family":"Olivieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6347-632X","authenticated-orcid":false,"given":"Annarita","family":"Savi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5716-7213","authenticated-orcid":false,"given":"Patrizia","family":"Magnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1288-1461","authenticated-orcid":false,"given":"Carla","family":"Canevari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4086-3713","authenticated-orcid":false,"given":"Simone","family":"Gusmini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7906-540X","authenticated-orcid":false,"given":"Diego","family":"Palumbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6535-1720","authenticated-orcid":false,"given":"Giorgia","family":"Guazzarotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3070-6632","authenticated-orcid":false,"given":"Luigi","family":"Augello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3293-4663","authenticated-orcid":false,"given":"Francesca","family":"Calabrese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4441-7962","authenticated-orcid":false,"given":"Stephanie","family":"Steidler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8651-5982","authenticated-orcid":false,"given":"Federica","family":"Cipriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4047-2585","authenticated-orcid":false,"given":"Margherita","family":"Rimini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6289-7202","authenticated-orcid":false,"given":"Andrea","family":"Casadei-Gardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7729-2468","authenticated-orcid":false,"given":"Luca","family":"Aldrighetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5806-1856","authenticated-orcid":false,"given":"Arturo","family":"Chiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4014-3711","authenticated-orcid":false,"given":"Francesco","family":"De Cobelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,20]]},"reference":[{"key":"1946_CR1","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1053\/j.gastro.2007.04.061","volume":"132","author":"HBKL El\u2013SeragRudolph","year":"2007","unstructured":"El\u2013SeragRudolph HBKL (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132:2557\u20132576. https:\/\/doi.org\/10.1053\/j.gastro.2007.04.061","journal-title":"Gastroenterology"},{"key":"1946_CR2","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","volume":"76","author":"M Reig","year":"2022","unstructured":"Reig M, Forner A, Rimola J, Ferrer-F\u00e0brega J, Burrel M, Garcia-Criado \u00c1 et al (2022) BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update. J Hepatol 76:681\u2013693. https:\/\/doi.org\/10.1016\/j.jhep.2021.11.018","journal-title":"J Hepatol"},{"key":"1946_CR3","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1148\/radiol.211806","volume":"303","author":"E Dhondt","year":"2022","unstructured":"Dhondt E, Lambert B, Hermie L, Huyck L, Vanlangenhove P, Geerts A et al (2022) 90 Y Radioembolization versus drug-eluting bead chemoembolization for unresectable hepatocellular carcinoma: results from the TRACE phase II randomized controlled trial. Radiology 303:699\u2013710. https:\/\/doi.org\/10.1148\/radiol.211806","journal-title":"Radiology"},{"key":"1946_CR4","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1002\/hep.31819","volume":"74","author":"R Salem","year":"2021","unstructured":"Salem R, Johnson GE, Kim E, Riaz A, Bishay V, Boucher E et al (2021) Yttrium-90 Radioembolization for the Treatment of Solitary, Unresectable HCC: The LEGACY Study. Hepatology 74:2342\u20132352. https:\/\/doi.org\/10.1002\/hep.31819","journal-title":"Hepatology"},{"key":"1946_CR5","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1007\/s00259-020-04976-8","volume":"48","author":"A Gabr","year":"2021","unstructured":"Gabr A, Riaz A, Johnson GE, Kim E, Padia S, Lewandowski RJ et al (2021) Correlation of Y90-absorbed radiation dose to pathological necrosis in hepatocellular carcinoma: confirmatory multicenter analysis in 45 explants. Eur J Nucl Med Mol Imaging 48:580\u2013583. https:\/\/doi.org\/10.1007\/s00259-020-04976-8","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1946_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2011\/398051","volume":"2011","author":"E Garin","year":"2011","unstructured":"Garin E, Rolland Y, Lenoir L, Pracht M, Mesbah H, Por\u00e9e P et al (2011) Utility of quantitative 99m Tc-MAA SPECT\/CT for 90 yttrium-labelled microsphere treatment planning: calculating vascularized hepatic volume and dosimetric approach. Int J Mol Imaging 2011:1\u20138. https:\/\/doi.org\/10.1155\/2011\/398051","journal-title":"Int J Mol Imaging"},{"key":"1946_CR7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13550-021-00764-z","volume":"11","author":"M Rodr\u00edguez-Fraile","year":"2021","unstructured":"Rodr\u00edguez-Fraile M, Ezponda A, Grisanti F, Mor\u00e1n V, Calvo M, Beri\u00e1n P et al (2021) The joint use of 99mTc-MAA-SPECT\/CT and cone-beam CT optimizes radioembolization planning. EJNMMI Res 11:23. https:\/\/doi.org\/10.1186\/s13550-021-00764-z","journal-title":"EJNMMI Res"},{"key":"1946_CR8","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s40658-021-00394-3","volume":"8","author":"C Chiesa","year":"2021","unstructured":"Chiesa C, Sjogreen-Gleisner K, Walrand S, Strigari L, Flux G, Gear J et al (2021) EANM dosimetry committee series on standard operational procedures: a unified methodology for 99mTc-MAA pre- and 90Y peri-therapy dosimetry in liver radioembolization with 90Y microspheres. EJNMMI Phys 8:77. https:\/\/doi.org\/10.1186\/s40658-021-00394-3","journal-title":"EJNMMI Phys"},{"key":"1946_CR9","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1007\/s00259-021-05600-z","volume":"49","author":"M Weber","year":"2022","unstructured":"Weber M, Lam M, Chiesa C, Konijnenberg M, Cremonesi M, Flamen P et al (2022) EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds. Eur J Nucl Med Mol Imaging 49:1682\u20131699. https:\/\/doi.org\/10.1007\/s00259-021-05600-z","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1946_CR10","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s00270-015-1146-8","volume":"39","author":"AF van den Hoven","year":"2016","unstructured":"van den Hoven AF, Prince JF, de Keizer B, Vonken E-JPA, Bruijnen RCG, Verkooijen HM et al (2016) Use of C-Arm Cone Beam CT During hepatic radioembolization: protocol optimization for extrahepatic shunting and parenchymal enhancement. Cardiovasc Intervent Radiol 39:64\u201373. https:\/\/doi.org\/10.1007\/s00270-015-1146-8","journal-title":"Cardiovasc Intervent Radiol"},{"key":"1946_CR11","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1148\/radiol.14131925","volume":"274","author":"V Tacher","year":"2015","unstructured":"Tacher V, Radaelli A, Lin M, Geschwind J-F (2015) How I Do It: cone-beam ct during transarterial chemoembolization for liver cancer. Radiology 274:320\u2013334. https:\/\/doi.org\/10.1148\/radiol.14131925","journal-title":"Radiology"},{"key":"1946_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jvir.2016.09.024","volume":"28","author":"SA Padia","year":"2017","unstructured":"Padia SA, Lewandowski RJ, Johnson GE, Sze DY, Ward TJ, Gaba RC et al (2017) Radioembolization of hepatic malignancies: background, quality improvement guidelines, and future directions. J Vasc Interv Radiol 28:1\u201315. https:\/\/doi.org\/10.1016\/j.jvir.2016.09.024","journal-title":"J Vasc Interv Radiol"},{"key":"1946_CR13","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3109\/13645706.2010.536243","volume":"20","author":"M Lin","year":"2011","unstructured":"Lin M, Loffroy R, Noordhoek N, Taguchi K, Radaelli A, Blijd J et al (2011) Evaluating tumors in transcatheter arterial chemoembolization (TACE) using dual-phase cone-beam CT. Minim Invasive Ther Allied Technol 20:276\u2013281. https:\/\/doi.org\/10.3109\/13645706.2010.536243","journal-title":"Minim Invasive Ther Allied Technol"},{"key":"1946_CR14","doi-asserted-by":"publisher","first-page":"W263","DOI":"10.2214\/AJR.07.2695","volume":"190","author":"BC Meyer","year":"2008","unstructured":"Meyer BC, Frericks BB, Voges M, Borchert M, Martus P, Justiz J et al (2008) Visualization of hypervascular liver lesions during TACE: comparison of angiographic C-Arm CT and MDCT. Am J Roentgenol 190:W263\u2013W269. https:\/\/doi.org\/10.2214\/AJR.07.2695","journal-title":"Am J Roentgenol"},{"key":"1946_CR15","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00270-011-0118-x","volume":"35","author":"R Loffroy","year":"2012","unstructured":"Loffroy R, Lin M, Rao P, Bhagat N, Noordhoek N, Radaelli A et al (2012) Comparing the detectability of hepatocellular carcinoma by C-Arm dual-phase cone-beam computed tomography during hepatic arteriography with conventional contrast-enhanced magnetic resonance imaging. Cardiovasc Intervent Radiol 35:97\u2013104. https:\/\/doi.org\/10.1007\/s00270-011-0118-x","journal-title":"Cardiovasc Intervent Radiol"},{"key":"1946_CR16","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1007\/s00259-015-3068-8","volume":"42","author":"C Chiesa","year":"2015","unstructured":"Chiesa C, Mira M, Maccauro M, Spreafico C, Romito R, Morosi C et al (2015) Radioembolization of hepatocarcinoma with 90Y glass microspheres: development of an individualized treatment planning strategy based on dosimetry and radiobiology. Eur J Nucl Med Mol Imaging 42:1718\u20131738. https:\/\/doi.org\/10.1007\/s00259-015-3068-8","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1946_CR17","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/s2468-1253(20)30290-9","volume":"6","author":"E Garin","year":"2021","unstructured":"Garin E, Tselikas L, Guiu B, Chalaye J, Edeline J, de Baere T et al (2021) Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial. Lancet Gastroenterol Hepatol 6:17\u201329. https:\/\/doi.org\/10.1016\/s2468-1253(20)30290-9","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"1946_CR18","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1148\/radiol.2020191606","volume":"296","author":"A-L Hermann","year":"2020","unstructured":"Hermann A-L, Dieudonn\u00e9 A, Ronot M, Sanchez M, Pereira H, Chatellier G et al (2020) Relationship of tumor radiation\u2013absorbed dose to survival and response in hepatocellular carcinoma treated with transarterial radioembolization with 90 y in the SARAH study. Radiology 296:673\u2013684. https:\/\/doi.org\/10.1148\/radiol.2020191606","journal-title":"Radiology"},{"key":"1946_CR19","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/bjc.1994.436","volume":"70","author":"W-Y Lau","year":"1994","unstructured":"Lau W-Y, Leung W-T, Ho S, Leung N, Chan M, Lin J et al (1994) Treatment of inoperable hepatocellular carcinoma with intrahepatic arterial yttrium-90 microspheres: a phase I and II study. Br J Cancer 70:994\u2013999. https:\/\/doi.org\/10.1038\/bjc.1994.436","journal-title":"Br J Cancer"},{"key":"1946_CR20","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.jvir.2023.03.011","volume":"34","author":"GM Knight","year":"2023","unstructured":"Knight GM, Gordon AC, Gates V, Talwar A, Riaz A, Salem R et al (2023) Evolution of personalized dosimetry for radioembolization of hepatocellular carcinoma. J Vasc Interv Radiol 34:1214\u20131225. https:\/\/doi.org\/10.1016\/j.jvir.2023.03.011","journal-title":"J Vasc Interv Radiol"},{"key":"1946_CR21","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1007\/s00259-020-05163-5","volume":"48","author":"H Levillain","year":"2021","unstructured":"Levillain H, Bagni O, Deroose CM, Dieudonn\u00e9 A, Gnesin S, Grosser OS et al (2021) International recommendations for personalised selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin microspheres. Eur J Nucl Med Mol Imaging 48:1570\u20131584. https:\/\/doi.org\/10.1007\/s00259-020-05163-5","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1946_CR22","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1007\/s00259-009-1210-1","volume":"36","author":"R Lhommel","year":"2009","unstructured":"Lhommel R, Goffette P, Van den Eynde M, Jamar F, Pauwels S, Bilbao JI et al (2009) Yttrium-90 TOF PET scan demonstrates high-resolution biodistribution after liver SIRT. Eur J Nucl Med Mol Imaging 36:1696\u20131696. https:\/\/doi.org\/10.1007\/s00259-009-1210-1","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1946_CR23","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1007\/s00259-011-1812-2","volume":"38","author":"F Giammarile","year":"2011","unstructured":"Giammarile F, Bodei L, Chiesa C, Flux G, Forrer F, Kraeber-Bodere F et al (2011) EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds. Eur J Nucl Med Mol Imaging 38:1393\u20131406. https:\/\/doi.org\/10.1007\/s00259-011-1812-2","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1946_CR24","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.2967\/jnumed.115.162685","volume":"56","author":"H Ilhan","year":"2015","unstructured":"Ilhan H, Goritschan A, Paprottka P, Jakobs TF, Fendler WP, Todica A et al (2015) Predictive value of 99m Tc-MAA SPECT for 90 Y-labeled resin microsphere distribution in radioembolization of primary and secondary hepatic tumors. J Nucl Med 56:1654\u20131660. https:\/\/doi.org\/10.2967\/jnumed.115.162685","journal-title":"J Nucl Med"},{"key":"1946_CR25","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.2967\/jnumed.112.117614","volume":"54","author":"M Wondergem","year":"2013","unstructured":"Wondergem M, Smits MLJ, Elschot M, de Jong HWAM, Verkooijen HM, van den Bosch MAAJ et al (2013) 99m Tc-macroaggregated albumin poorly predicts the intrahepatic distribution of 90 Y resin microspheres in hepatic radioembolization. J Nucl Med 54:1294\u20131301. https:\/\/doi.org\/10.2967\/jnumed.112.117614","journal-title":"J Nucl Med"},{"key":"1946_CR26","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13550-023-01011-3","volume":"13","author":"M Riveira-Martin","year":"2023","unstructured":"Riveira-Martin M, Akhavanallaf A, Mansouri Z, Bianchetto Wolf N, Salimi Y, Ricoeur A et al (2023) Predictive value of 99mTc-MAA-based dosimetry in personalized 90Y-SIRT planning for liver malignancies. EJNMMI Res 13:63. https:\/\/doi.org\/10.1186\/s13550-023-01011-3","journal-title":"EJNMMI Res"},{"key":"1946_CR27","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.diii.2020.09.003","volume":"102","author":"M Martin","year":"2021","unstructured":"Martin M, Hocquelet A, Debordeaux F, Bordenave L, Blanc J-F, Papadopoulos P et al (2021) Comparison of perfused volume segmentation between cone-beam CT and 99mTc-MAA SPECT\/CT for treatment dosimetry before selective internal radiation therapy using 90Y-glass microspheres. Diagn Interv Imaging 102:45\u201352. https:\/\/doi.org\/10.1016\/j.diii.2020.09.003","journal-title":"Diagn Interv Imaging"},{"key":"1946_CR28","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1016\/j.jvir.2022.08.027","volume":"33","author":"N Kokabi","year":"2022","unstructured":"Kokabi N, Webster LA, Elsayed M, Switchenko JM, Chen B, Brandon D et al (2022) Accuracy and safety of scout dose resin Yttrium-90 microspheres for radioembolization therapy treatment planning: a prospective single-arm clinical trial. J Vasc Interv Radiol 33:1578-1587.e5. https:\/\/doi.org\/10.1016\/j.jvir.2022.08.027","journal-title":"J Vasc Interv Radiol"},{"key":"1946_CR29","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1007\/s00259-014-2784-9","volume":"41","author":"M Elschot","year":"2024","unstructured":"Elschot M, Nijsen JFW, Lam MGEH, Smits MLJ, Prince JF, Viergever MA et al (2024) 99mTc-MAA overestimates the absorbed dose to the lungs in radioembolization: a quantitative evaluation in patients treated with 166Ho-microspheres. Eur J Nucl Med Mol Imaging 41:1965\u20131975. https:\/\/doi.org\/10.1007\/s00259-014-2784-9","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1946_CR30","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1007\/s00270-021-02898-y","volume":"44","author":"SI Stein","year":"2021","unstructured":"Stein SI, Soliman MM, Sparapani J, Doustaly R, Cobb BW, Malhotra A et al (2021) Conventional hepatic volumetry may lead to inaccurate segmental Yttrium-90 radiation dosimetry. Cardiovasc Intervent Radiol 44:1973\u20131985. https:\/\/doi.org\/10.1007\/s00270-021-02898-y","journal-title":"Cardiovasc Intervent Radiol"},{"key":"1946_CR31","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1007\/s10439-020-02469-1","volume":"48","author":"E Roncali","year":"2020","unstructured":"Roncali E, Taebi A, Foster C, Vu CT (2020) Personalized dosimetry for liver cancer Y-90 radioembolization using computational fluid dynamics and monte carlo simulation. Ann Biomed Eng 48:1499\u20131510. https:\/\/doi.org\/10.1007\/s10439-020-02469-1","journal-title":"Ann Biomed Eng"}],"updated-by":[{"DOI":"10.1007\/s11547-025-02031-w","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T00:00:00Z","timestamp":1750636800000}}],"container-title":["La radiologia medica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-024-01946-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11547-024-01946-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-024-01946-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T13:54:43Z","timestamp":1750686883000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11547-024-01946-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,20]]},"references-count":31,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["1946"],"URL":"https:\/\/doi.org\/10.1007\/s11547-024-01946-0","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s11547-025-02031-w","asserted-by":"object"}]},"ISSN":["1826-6983"],"issn-type":[{"value":"1826-6983","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,20]]},"assertion":[{"value":"5 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s11547-025-02031-w","URL":"https:\/\/doi.org\/10.1007\/s11547-025-02031-w","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments (EC approval 64\/INT\/2021).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study as described by Institutional Ethic Committee approval (64\/INT\/2021).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Consent for publication was obtained for every individual person\u2019s data included in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}